welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Tucson drug startup launches gastric-cancer trial
Tucson-based drug startup Cancer Prevention Pharmaceuticals Inc. has announced the launch of a Phase 2 clinical trial at Vanderbilt University Medical Center to test the company’s flagship drug candidate for preventing gastric cancer.
The drug, CPP-1X, will be studied in patients with precancerous gastric lesions who are at high risk for gastric cancer, the company said Monday.
The trial is funded by the National Cancer Institute and run in collaboration with gastroenterologists Dr. Keith T. Wilson and Dr. Douglas R. Morgan of the Vanderbilt University School of Medicine and the Vanderbilt-Ingram Cancer Center.
expertly curated content related to this topic
-
Intestinal Polyps in KidsThe lining of the intestine is normally ...
-
Colorectal Polyposis: Clinical Presentation and Surgical TreatmentKEYWORDS: colorectal cancer; colorectal...
-
Nonsteroidal Anti-Inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesNumerous experimental, epidemiologic, an...
-
Cancer Prevention Pharmaceuticals announces last patient completes phase 3 trial protocol of CPP-1X/sul for familial...Cancer Prevention Pharmaceutic...
-
Macroscopic and Histologic Regression of Duodenal Polyposis with FOLFOX4 Chemotherapy for an Ileal Pouch Adenocarcin...Severe (stage IV) duodenal polyposis is ...
-
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Ad...Evidence supporting aspirin and resistan...
-
Woman with Ostomy Bag Refused Entry to Bathroom with Disability AccessThat’s the message English blogger Sam...